https://www.selleckchem.com/products/tvb-3166.html
Differentiated thyroid cancer (DTC) is the most common thyroid tumor, and the cells of DTC patients can lose the ability to differentiate in their natural state or during treatment and develop radioiodine-refractory DTC (RAI-R DTC), resulting in increased malignancy. Monocarboxylate transporter-1 ( ) is positively correlated with the level of malignant of various tumors, and its expression in RAI-R DTC cells is correlated with their biological cell traits. Data from 14 iodine-refractory thyroid carcinoma patients were collected, and th
Like
Comment
Share
